http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102861026-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac31afbea1cbbb03498644721ffb4a62
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16
filingDate 2012-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c743184ad2c5bec8f25fab02ca247776
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90dd0196e1bf2c64c8fcbe74cef0b29c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_719b0310d7da41ad2fcd37b6576318a2
publicationDate 2014-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102861026-B
titleOfInvention Application of Gypensapogenin A in medicine for treating influenza virus A
abstract The invention discloses application of Gypensapogenin A in preparing a medicine for treating influenza virus A. Experiments prove that Gypensapogenin A has obvious inhibiting effect to influenza virus A (fluA), which prompts the potential application value of Gypensapogenin A in the field of treating infectious diseases of influenza virus A. The application of Gypensapogenin A in preparing the medicine for treating influenza virus A infection, which is provided by the invention, is disclosed for the first time. The skeleton type belongs to brand-new skeleton type, and the influenza virus inhibiting activity of Gypensapogenin A is extremely strong, so that no possibility for providing any prompt by other compounds exists. Gypensapogenin A has outstanding actual characteristics. Meanwhile, Gypensapogenin A has outstanding progress when being used for preventing and treating influenza virus infection.
priorityDate 2012-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426352452
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID182084
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451743945
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID182084
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID11320
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11105
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID44586
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID11320
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID11309
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID11309
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID44586
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57403926

Total number of triples: 26.